Girolline, an antitumor compound isolated from a sponge, induces G2/M cell cycle arrest and accumulation of polyubiquitinated p53

被引:30
作者
Tsukamoto, S [1 ]
Yamashita, K
Tane, K
Kizu, R
Ohta, T
Matsunaga, S
Fusetani, N
Kawahara, H
Yokosawa, H
机构
[1] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9200934, Japan
[2] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat Nat Prod, Tokyo 1138657, Japan
[3] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biochem, Sapporo, Hokkaido 0600812, Japan
关键词
girolline; cell cycle; ubiquitin; p53; proteasome;
D O I
10.1248/bpb.27.699
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Girolline, an antitumor compound isolated from a sponge, has been reported to inhibit the termination step of protein synthesis in vivo. In this study, we found that girolline induced G2/M cell cycle arrest in several tumor cell lines. Immunochemical analysis revealed that polyubiquitinated p53 was accumulated in girolline-treated cells, while other polyubiquitinated cellular proteins were not accumulated, indicating that the effect of girolline is specific for p53. On the other hand, girolline did not inhibit proteasome activity in vitro, and accumulation of polyubiquitinated p53 was scarcely detected in the presence of leptomycin B, an inhibitor of nuclear export. Based on the above findings, we propose that girolline affects the step of recruitment of polyubiquitinated p53 to the proteasome.
引用
收藏
页码:699 / 701
页数:3
相关论文
共 17 条
[1]  
AHOND A, 1988, CR ACAD SCI II, V307, P145
[2]   p53-Mdm2 - the affair that never ends [J].
Alarcon-Vargas, D ;
Ronai, Z .
CARCINOGENESIS, 2002, 23 (04) :541-547
[3]   PHASE-I STUDY OF RP 49532A, A NEW PROTEIN-SYNTHESIS INHIBITOR, IN PATIENTS WITH ADVANCED REFRACTORY SOLID TUMORS [J].
CATIMEL, G ;
COQUARD, R ;
GUASTALLA, JP ;
MERROUCHE, Y ;
LEBAIL, N ;
ALAKL, MK ;
DUMORTIER, A ;
FOY, M ;
CLAVEL, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (03) :246-248
[4]   MODE OF ACTION OF THE ANTITUMOR COMPOUND GIRODAZOLE (RP-49532A, NSC-627434) [J].
COLSON, G ;
RABAULT, B ;
LAVELLE, F ;
ZERIAL, A .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (08) :1717-1723
[5]   Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6 [J].
Freedman, DA ;
Levine, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :7288-7293
[6]   PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC TO MULTI-UBIQUITIN CHAINS OF POLYUBIQUITINATED PROTEINS [J].
FUJIMURO, M ;
SAWADA, H ;
YOKOSAWA, H .
FEBS LETTERS, 1994, 349 (02) :173-180
[7]   The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction [J].
Glickman, MH ;
Ciechanover, A .
PHYSIOLOGICAL REVIEWS, 2002, 82 (02) :373-428
[8]   Degradation of p27Kip1 at the G0-G1 transition mediated by a Skp2-independent ubiquitination pathway [J].
Hara, T ;
Kamura, T ;
Nakayama, K ;
Oshikawa, K ;
Hatakeyama, S ;
Nakayama, KI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) :48937-48943
[9]   Transferring substrates to the 26S proteasome [J].
Hartmann-Petersen, R ;
Seeger, M ;
Gordon, C .
TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (01) :26-31
[10]   The ubiquitin system [J].
Hershko, A ;
Ciechanover, A .
ANNUAL REVIEW OF BIOCHEMISTRY, 1998, 67 :425-479